‹ REGN latest research

REGN (Regeneron Pharmaceuticals, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed REGN on 4 market nights between July 31, 2026 and September 18, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

4 calls 4 BUY · 0 HOLD · 0 SELL BUY calls up after 20 trading days: 3 of 3
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
September 18, 2026 BUY $789.45 $908.50 / $671.50 +0.4% not yet
The setup suggests a short-term oversold bounce with longer-term fundamental strength.
August 6, 2026 BUY $768.58 $825.00 / $658.75 +4.4% +9.2%
The post-earnings drift signal and strong fundamental backing suggest a multi-week upward trend.
August 5, 2026 BUY $760.66 — / — +3.8% +10.9%
Continued positive impact from strong Q2 earnings and product growth.
July 31, 2026 BUY $738.34 $812.17 / $627.49 +2.9% +4.1%
The post-earnings drift signal suggests a multi-week upward trend.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.